Cardiff Oncology, Inc. (NASDAQ:CRDF) Q4 2023 Earnings Call Transcript
Cardiff Oncology, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.26.
March 2nd, 2024 - News Transcripts
November 3rd, 2023 - News Transcripts
September 23rd, 2021 - Hedge Funds Insider Trading
December 16th, 2020 - Hedge Funds News
Returns since its inception in May 2014 (through Feb 16th, 2024)